228 related articles for article (PubMed ID: 31637138)
1. Identification of key genes and multiple molecular pathways of metastatic process in prostate cancer.
Guo L; Lin M; Cheng Z; Chen Y; Huang Y; Xu K
PeerJ; 2019; 7():e7899. PubMed ID: 31637138
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
Gu P; Yang D; Zhu J; Zhang M; He X
Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
Dai H; Guo L; Lin M; Cheng Z; Li J; Tang J; Huan X; Huang Y; Xu K
PeerJ; 2020; 8():e10265. PubMed ID: 33240619
[TBL] [Abstract][Full Text] [Related]
4. Identification of the hub genes associated with prostate cancer tumorigenesis.
Zhu H; Lin Q; Gao X; Huang X
Front Oncol; 2023; 13():1168772. PubMed ID: 37251946
[TBL] [Abstract][Full Text] [Related]
5. The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer.
Song Z; Huang Y; Zhao Y; Ruan H; Yang H; Cao Q; Liu D; Zhang X; Chen K
J Cancer; 2019; 10(6):1398-1408. PubMed ID: 31031850
[No Abstract] [Full Text] [Related]
6. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
8. Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
Lin J; Chen Z; Li Z; Nong D; Li X; Huang G; Hao N; Liang J; Li W
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296309
[TBL] [Abstract][Full Text] [Related]
9. CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer.
Dai L; Song ZX; Wei DP; Zhang JD; Liang JQ; Wang BB; Ma WT; Li LY; Dang YL; Zhao L; Zhang LM; Zhao YM
Adv Ther; 2021 Jun; 38(6):2973-2989. PubMed ID: 33881746
[TBL] [Abstract][Full Text] [Related]
10. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
11. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
Front Genet; 2020; 11():530892. PubMed ID: 33061942
[TBL] [Abstract][Full Text] [Related]
12. Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis.
Cao L; Chen Y; Zhang M; Xu DQ; Liu Y; Liu T; Liu SX; Wang P
PeerJ; 2018; 6():e5180. PubMed ID: 30002985
[TBL] [Abstract][Full Text] [Related]
13. Identification of key candidate genes and biological pathways in bladder cancer.
Gao X; Chen Y; Chen M; Wang S; Wen X; Zhang S
PeerJ; 2018; 6():e6036. PubMed ID: 30533316
[TBL] [Abstract][Full Text] [Related]
14. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
15. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the molecular mechanisms underlying metastasis in prostate cancer by gene expression profiling.
Zhang X; Yao X; Qin C; Luo P; Zhang J
Exp Ther Med; 2016 Aug; 12(2):925-932. PubMed ID: 27446297
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma.
Zhang L; Makamure J; Zhao D; Liu Y; Guo X; Zheng C; Liang B
Exp Ther Med; 2020 Jul; 20(1):427-435. PubMed ID: 32537007
[TBL] [Abstract][Full Text] [Related]
18. Identification of key genes in prostate cancer gene expression profile by bioinformatics.
Lu W; Ding Z
Andrologia; 2019 Feb; 51(1):e13169. PubMed ID: 30311263
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.
Deng L; Gu X; Zeng T; Xu F; Dong Z; Liu C; Chao H
Oncol Lett; 2019 Sep; 18(3):3236-3248. PubMed ID: 31452801
[TBL] [Abstract][Full Text] [Related]
20. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
